基于寡核酸的基因疗法在基因沉默中的有效性
Christina Patra1, Zain Hussein1, Veronika D Ace1
1Laboratory of DNA-nanosensor diagnostics, ITMO University, Saint-Petersburg, 191002, Russian Federation.
Theranostics
|December 5, 2025
概括
基于寡核酸的基因疗法显示出希望,但在达到目标RNA和实现所需基因淘汰方面面临挑战. 目前的治疗方法有限,突出了潜在和临床有效性之间的差距.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 基于寡核酸的基因疗法 (OGTs) 为疾病治疗提供mRNA水平的基因调制.
- 取得了显著的进展,但临床疗效往往远远低于预期.
- 低细胞分裂释放和有限的基因敲击阻碍了OGT的有效性.
研究的目的:
- 批判性地评估影响OGT治疗疗效的因素.
- 突出OGT理论承诺与临床现实之间的差距.
- 讨论siRNA开发和商业化方面的挑战.
主要方法:
- 关于OGT疗效的当前文献的综述.
- 对限制OGT细胞吸收和活动的因素的分析.
- 反感性寡核酸 (ASOs) 和小干扰RNA (siRNAs) 的比较.
主要成果:
- 不到1%的转染的OGT到达细胞质,限制了向RNA的相互作用.
- 只有大约2%的siRNA在体外实现了70%的目标基因淘汰.
- 经批准的OGT显示出边际益处,主要用于缺乏替代品的疾病.
结论:
- 持续存在的挑战限制了OGTs的临床转化.
- siRNAs面临着诸如非目标效应和不成熟的设计策略等障碍.
- 弥合OGT潜力和临床现实之间的差距需要进一步的研究和开发.
相关概念视频
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K


